Who is sponsoring NCT05615090?

NCT05615090 is sponsored by Gangnam Severance Hospital.

What drugs are being tested in NCT05615090?

Interventions in NCT05615090: Arm I (Prepectoral),, Arm II (Subpectoral).

What condition does NCT05615090 study?

NCT05615090 studies Eating Disorder in Adolescents and Young Adults.

Is NCT05615090 still recruiting?

NCT05615090 is currently recruiting now. Last updated 16 April 2024.

Last reviewed 2024-04-16 · How we verify

NCT05615090

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Self-help Application for Eating Disorder

Recruiting now NA Last updated 16 April 2024

What this trial tests

NA trial testing Arm I (Prepectoral), in Eating Disorder in Adolescents and Young Adults in 120 participants. Currently enrolling.

Timeline

27 January 2023

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	Gangnam Severance Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	120
Start date	27 January 2023
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	1 location across South Korea

Drugs / interventions tested

Arm I (Prepectoral),
Arm II (Subpectoral)

Conditions studied

Eating Disorder in Adolescents and Young Adults — all drugs for Eating Disorder in Adolescents and Young Adults →

Sponsor

Gangnam Severance Hospital

Who can join

Adults 13 to 22, any sex, with Eating Disorder in Adolescents and Young Adults. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether mobile-based self-help CBT-E treatment for eating disorder can reduce eating disorder symptoms compared to the waitlist group

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Feasibility and clinical outcomes of tailored digital CBT-E guided self-help for youth with binge-eating symptoms: A pilot randomized controlled trial.
Oh H, Lee U, Shin B, Kim Y, et al · · 2026 · PMID 42088594 · DOI 10.1016/j.invent.2026.100945

Verify or expand the search:

Other Gangnam Severance Hospital trials

Trials by the same sponsor.

NCT07505628 — AI-based Rehabilitation for Hip and Knee Surgery Patients · NA · not yet recruiting
NCT07311122 — Endocrine Therapy Base on 21-gene RS · not yet recruiting
NCT07011823 — Immune-checkpoint Blockade After Partial Breast Irradiation by Pembrolizumab in Early TNBC · Phase 2 · not yet recruiting
NCT07211451 — Axillary Nodal Burden in HER2+ and TNBC · completed
NCT06839716 — Comparison of Ropivacaine-Poloxamer 407 Hydrogel and TAP Block for Postoperative Pain Management in Laparoscopic/Robotic · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05615090 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gangnam Severance Hospital
Last refreshed: 16 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05615090.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing